128 related articles for article (PubMed ID: 12843757)
1. Response to Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.
Halpern SD
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):412. PubMed ID: 12843757
[No Abstract] [Full Text] [Related]
2. Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents.
Giocos G; Kagee A; Swartz L
AIDS Behav; 2008 Nov; 12(6):842-51. PubMed ID: 17668313
[TBL] [Abstract][Full Text] [Related]
3. Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.
O'Connell JM; Hogg RS; Chan K; Strathdee SA; McLean N; Martindale SL; Willoughby B; Remis R
J Acquir Immune Defic Syndr; 2002 Dec; 31(5):521-8. PubMed ID: 12473841
[TBL] [Abstract][Full Text] [Related]
4. Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users.
Dhalla S; Poole G; Singer J; Patrick DM; Wood E; Kerr T
Vaccine; 2010 Feb; 28(7):1663-7. PubMed ID: 20044049
[TBL] [Abstract][Full Text] [Related]
5. Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
Connochie D; Tingler RC; Bauermeister JA
Vaccine; 2019 Oct; 37(43):6494-6499. PubMed ID: 31522806
[TBL] [Abstract][Full Text] [Related]
6. Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda.
Kiwanuka N; Robb M; Kigozi G; Birx D; Philips J; Wabwire-Mangen F; Wawer MJ; Nalugoda F; Sewankambo NK; Serwadda D; Gray RH
J Acquir Immune Defic Syndr; 2004 Jun; 36(2):721-5. PubMed ID: 15167291
[TBL] [Abstract][Full Text] [Related]
7. Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand.
Jenkins RA; Chinaworapong S; Morgan PA; Ruangyuttikarn C; Sontirat A; Chiu J; Michael RA; Nitayaphan S; Khamboonruang C
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):171-7. PubMed ID: 9637582
[TBL] [Abstract][Full Text] [Related]
8. HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.
Aliyu G; Mohammad M; Saidu A; Mondal P; Charurat M; Abimiku A; Nasidi A; Blattner W
AIDS Care; 2010 Oct; 22(10):1277-84. PubMed ID: 20661789
[TBL] [Abstract][Full Text] [Related]
9. Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-positive injection drug users.
Dhalla S; Poole G; Singer J; Patrick DM; Kerr T
Psychol Health Med; 2012; 17(2):223-34. PubMed ID: 22250925
[TBL] [Abstract][Full Text] [Related]
10. Motivators to participation in actual HIV vaccine trials.
Dhalla S; Poole G
AIDS Behav; 2014 Feb; 18(2):263-77. PubMed ID: 23736885
[TBL] [Abstract][Full Text] [Related]
11. Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.
Koblin BA; Holte S; Lenderking B; Heagerty P
J Acquir Immune Defic Syndr; 2000 Aug; 24(5):451-7. PubMed ID: 11035616
[TBL] [Abstract][Full Text] [Related]
12. Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men.
Li Q; Luo F; Zhou Z; Li S; Liu Y; Li D; Shi W; Raymond HF; Ruan Y; Shao Y
Vaccine; 2010 Jun; 28(29):4638-43. PubMed ID: 20452428
[TBL] [Abstract][Full Text] [Related]
13. Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study.
Mayanja Y; Abaasa A; Namale G; Price MA; Kamali A
BMC Public Health; 2020 Nov; 20(1):1789. PubMed ID: 33239018
[TBL] [Abstract][Full Text] [Related]
14. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US.
Priddy FH; Cheng AC; Salazar LF; Frew PM
Int J STD AIDS; 2006 Feb; 17(2):99-102. PubMed ID: 16464270
[TBL] [Abstract][Full Text] [Related]
15. Pediatric HIV type 1 vaccine trial acceptability among mothers in Kenya.
Farquhar C; John-Stewart GC; John FN; Kabura MN; Kiarie JN
AIDS Res Hum Retroviruses; 2006 Jun; 22(6):491-5. PubMed ID: 16796522
[TBL] [Abstract][Full Text] [Related]
16. Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
Nyasani DK; Mutua GN; Sajabi RM; Ng'ang'a JW; Gachie JN; Maina AM; Lusike LL; Anzala AO; Price MA; Manyonyi GO
PLoS One; 2018; 13(11):e0206656. PubMed ID: 30388145
[TBL] [Abstract][Full Text] [Related]
17. Recruitment using respondent driven sampling, risk behaviors assessment and willingness of young female sex workers (18-25 years) in Dar Es Salaam, Tanzania to participate in HIV vaccine trials.
Mbunda T; Tarimo EAM; Bakari M; Sandström E; Kulane A
BMC Public Health; 2019 Nov; 19(1):1537. PubMed ID: 31796002
[TBL] [Abstract][Full Text] [Related]
18. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
[TBL] [Abstract][Full Text] [Related]
19. Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note.
Chesney MA; Chambers DB; Kahn JO
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(4):266-71. PubMed ID: 9402073
[TBL] [Abstract][Full Text] [Related]
20. Correlates of HIV vaccine trial participation: an Indian perspective.
Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
